赵兴洪-太阳集团网站入口官网

导师类型

硕士生导师

办公地点

6教308

职称/职务

副教授

电子邮箱

xinghong.zhao@sicau.edu.cn

研究方向

新型肽类抗菌剂（基因组发掘与生物合成）、仿生纳米载药系统、细菌耐药性防控

学术、技术组织任职/头衔

四川省特聘专家、入选四川省“天府峨眉计划”、荷兰皇家微生物学学会会员、美国微生物学会会员、frontiers in microbiology(if=6.604, top)客座编辑（guest editor）。

教育背景及工作经历

2023/03至今四川农业大学副教授

2021/08-2023/02 四川农业大学特聘副教授

2020/06–2021/08荷兰格罗宁根大学微生物与生化药学博士后

2017/08–2020/06荷兰格罗宁根大学微生物与生化药学博士

教学课程

生物技术制药、仪器分析（药）、药学专业英语

人才培养情况

指导在读硕士生5名、本科生14名。

科研项目

（近五年）

1、天府英才工程专项，2023.04-2026.03，在研，主持

2、四川省国际科技创新合作项目，202201-202312，结题，主持

3、四川农业大学引进人才科研启动项目，202108-202607，在研，主持

4、四川省博士后科研项目特别资助，202307-202507，在研，主持

主要论著、

代表性论文

现已发表sci收录论文30余篇，累计被引1200余次，h指数20。研究成果发表在包括naturecommunications、cell chemical biology、journal of controlled release、advanced healthcare materials、international journal of biological macromolecules和antimicrobialagents and chemotherapy等权威期刊。

[1]xinghong zhao^#,*, xinyi zhong^#, shinong yang^#, jiarong deng, kai deng, zhengqun huang, yuanfeng li, zhongqiong yin*, yong liu*, jakob h. viel, and hongping wan*. "guiding antibiotics towards their target using bacteriophage proteins."naturecommunications,2024, 15: 5287.（if = 16.6，物理第一作者兼共同通讯作者）

[2]xinghong zhao, zhibo li, and oscar p. kuipers*. "mimicry of a non-ribosomally produced antimicrobial, brevicidine, by ribosomal synthesis and post-translational modification."cell chemical biology,2020, 27(10): 1262-1271.（if = 9.039，第一作者）

[3] kai deng^#, zhengqun huang^#, bo jing, lin zhu, yumei feng, qin jiang, zhiwen xu, hongping wan*, andxinghong zhao*. "mucoadhesive chitosan-catechol as an efficient vaccine delivery system for intranasal immunization."international journal of biological macromolecules,2024, 133008.（if = 8.2，最后通讯作者）

[4] yumeng wang^#,xinghong zhao^#, xingjian zhou^#, juqin dai, xiaowen hu, yinzi piao, guangyue zu, jian xiao*, keqing shi*, yong liu*, yuanfeng li*, and linqi shi. "a supramolecular hydrogel dressing with antibacterial, immunoregulation, and pro-regeneration ability for biofilm-associated wound healing."journal of controlled release,2024, 368:740-755.（if = 10.8，共同第一作者）

[5] hongping wan^#,*, kai deng^#, zhengqun huang^#, yunhan yang, bo jing, yumei feng, yuanfeng li, yong liu, mingqin liu, andxinghong zhao*. "pathogen-mimicking nanoparticles based on rigid nanomaterials as an efficient subunit vaccine delivery system for intranasal iimmunization."advanced healthcare materials,2024, 2401120.（if = 10，最后通讯作者）

[6]xinghong zhao^#,*, xinyi zhong^#, shinong yang^#, kai deng, lu liu, xu song, yuanfeng zou, lixia li, xun zhou, renyong jia, juchun lin, huaqiao tang, gang ye, jianqing yang, shan zhao, yifei lang, hongping wan*, zhongqiong yin*, and oscar p. kuipers. "elucidating the mechanism of action of the gram-negative-pathogen-selective cyclic antimicrobial lipopeptide brevicidine."antimicrobial agents and chemotherapy,2023:e00010-23.（if = 5.938，物理第一作者兼共同通讯作者）

[7]xinghong zhao, zhongqiong yin, eefjan breukink, gert n. moll, and oscar p. kuipers*. "an engineered double lipid ii binding motifs-containing lantibiotic displays potent and selective antimicrobial activity against enterococcus faecium."antimicrobial agents and chemotherapy,2020, 64(6): e02050-19.（if = 5.938，第一作者）

[8] roderick corstiaan abraham versloot, patricia arias-orozco, matthijs jonathan tadema, florian leonardus rudolfus lucas,xinghong zhao, siewert j. marrink, oscar paul kuipers, and giovanni maglia*. "seeing the invisibles: detection of peptide enantiomers, diastereomers, and isobaric ring formation in lanthipeptides using nanopores."journal of the american chemical society,2023, 145(33):18355-18365.（if = 15）

[9]xinghong zhao, and oscar p. kuipers*. "nisin-and ripcin-derived hybrid lanthipeptides display selective antimicrobial activity against staphylococcus aureus."acs synthetic biology,2021, 10(7): 1703-1714.（if = 5.249，第一作者）

[10]xinghong zhao, and oscar p. kuipers*. "synthesis of silver-nisin nanoparticles with low cytotoxicity as antimicrobials against biofilm-forming pathogens"colloids and surfaces b: biointerfaces,2021, 206: 111965.（if = 5.999，第一作者）